RAC 1.27% $1.55 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-24

  1. 685 Posts.
    lightbulb Created with Sketch. 120
    What i believe is new news is the discussions being had with Dr Sabnis and the interest in Bisantrene potentially being a paediatric AML treatment.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.